Page last updated: 2024-11-06

mitomycin and Heart Failure

mitomycin has been researched along with Heart Failure in 7 studies

Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.

Heart Failure: A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION.

Research Excerpts

ExcerptRelevanceReference
"Forty-six patients with recurrent metastatic breast cancer were treated with a combination chemotherapy including doxorubicin and mitomycin C."3.67Possible enhancement of the cardiotoxicity of doxorubicin when combined with mitomycin C. ( Brambilla, MC; Comazzi, R; Genitoni, V; Guindani, A; Lacaita, G; Villani, F; Volonterio, A, 1985)
"A 23-year-old male patient with plasma cell leukemia showed characteristic clinical features: accelerating heart failure and consciousness disturbance accompanied with an increase of plasma cells in peripheral blood."1.29[Primary plasma cell leukemia complicated with high-output cardiac failure and hyperammonemia]. ( Hata, H; Kawaguchi, T; Kuribayashi, N; Matsuzaki, H; Nakahashi, E; Shimizu, K; Takatsuki, K; Tsuji, N, 1994)
"Two percent had congestive heart failure associated with doxorubicin."1.27Early and delayed clinical cardiotoxicity of doxorubicin. ( Blumenschein, GR; Buzdar, AU; Marcus, C; Smith, TL, 1985)

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19904 (57.14)18.7374
1990's2 (28.57)18.2507
2000's0 (0.00)29.6817
2010's1 (14.29)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rjiba-Touati, K1
Ayed-Boussema, I1
Belarbia, A1
Mokni, M1
Achour, A1
Bacha, H1
Abid, S1
Nakahashi, E1
Kuribayashi, N1
Tsuji, N1
Kawaguchi, T1
Hata, H1
Matsuzaki, H1
Shimizu, K1
Takatsuki, K1
Mackintosh, J1
Sivanesaratnam, V1
Verweij, J1
Stoter, G1
Buzdar, AU1
Marcus, C1
Smith, TL1
Blumenschein, GR1
Villani, F1
Comazzi, R1
Lacaita, G1
Guindani, A1
Genitoni, V1
Volonterio, A1
Brambilla, MC1

Reviews

1 review available for mitomycin and Heart Failure

ArticleYear
Severe side effects of the cytotoxic drug mitomycin-C.
    The Netherlands journal of medicine, 1987, Volume: 30, Issue:1-2

    Topics: Animals; Heart Failure; Hepatic Veno-Occlusive Disease; Humans; Kidney Diseases; Mitomycin; Mitomyci

1987

Other Studies

6 other studies available for mitomycin and Heart Failure

ArticleYear
Role of recombinant human erythropoietin against mitomycin C-induced cardiac, hepatic and renal dysfunction in Wistar rats.
    Human & experimental toxicology, 2015, Volume: 34, Issue:5

    Topics: Animals; Antibiotics, Antineoplastic; Cardiotoxicity; Chemical and Drug Induced Liver Injury; Drug A

2015
[Primary plasma cell leukemia complicated with high-output cardiac failure and hyperammonemia].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1994, Volume: 35, Issue:8

    Topics: Adult; Ammonia; Antineoplastic Combined Chemotherapy Protocols; Cardiac Output; Dexamethasone; Doxor

1994
Cardiopulmonary complications of mitomycin-C.
    The Medical journal of Australia, 1990, Jan-01, Volume: 152, Issue:1

    Topics: Anemia, Hemolytic; Female; Heart Failure; Humans; Hypertension, Pulmonary; Middle Aged; Mitomycin; M

1990
Mitomycin-C cardiotoxicity.
    The Medical journal of Australia, 1989, Sep-04, Volume: 151, Issue:5

    Topics: Carcinoma, Squamous Cell; Female; Heart Failure; Humans; Middle Aged; Mitomycin; Mitomycins; Uterine

1989
Early and delayed clinical cardiotoxicity of doxorubicin.
    Cancer, 1985, Jun-15, Volume: 55, Issue:12

    Topics: Adult; Aged; Anthraquinones; Antineoplastic Combined Chemotherapy Protocols; Cardiomyopathies; Cyclo

1985
Possible enhancement of the cardiotoxicity of doxorubicin when combined with mitomycin C.
    Medical oncology and tumor pharmacotherapy, 1985, Volume: 2, Issue:2

    Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neo

1985